Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$32.2 - $43.61 $3,992 - $5,407
124 New
124 $4,000
Q1 2021

May 14, 2021

SELL
$70.65 - $96.76 $640,300 - $876,935
-9,063 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$41.13 - $62.45 $372,761 - $565,984
9,063 New
9,063 $554,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.